FIELD: medicine.
SUBSTANCE: patient's blood serum is examined for the initial alveomucine content. If the value is within the range to 45.0 Units/ml enables predicting a low risk of developing respiratory insufficiency; if the present level is exceeded, and the value gains in progression, a high risk of developing respiratory insufficiency in progression is predicted.
EFFECT: use of the invention enables short-term prediction of a risk of developing respiratory insufficiency in the patients suffering hemorrhagic fever and renal syndrome.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING DEVELOPMENT OF COMPLICATIONS OF HEMORRHAGIC FEVER WITH RENAL SYNDROME IN EARLY PERIOD OF DISEASE | 2010 |
|
RU2433407C1 |
METHOD OF SEVERITY ASSESSMENT FOR HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2009 |
|
RU2392858C1 |
METHOD FOR PREDICTION OF SEVERE HAEMORRHAGIC FEVER WITH RENAL SYNDROME AT EARLY STAGES OF DISEASE | 2022 |
|
RU2790962C1 |
METHOD FOR TREATMENT OF PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROME IN CASE OF LIVER DYSFUNCTION DEVELOPMENT | 2016 |
|
RU2645067C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPMENT OF SEVERE HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2009 |
|
RU2406450C1 |
METHOD FOR EVALUATING HEMORRHAGIC FEVER SEVERITY WHEN AGGRAVATED WITH RENAL SYNDROME | 1998 |
|
RU2155337C1 |
METHOD FOR EVALUATING GRAVITY OF CONDITION OF PATIENTS AFFECTED WITH HEMORRHAGIC FEVER COMPLICATED WITH NEPHRITE SYNDROME | 1993 |
|
RU2104533C1 |
METHOD FOR TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2002 |
|
RU2228196C1 |
NONINVASIVE METHOD FOR PREDICTING RENAL RUPTURES AT HEMORRHAGIC FEVER ACCOMPANIED WITH RENAL SYNDROME | 2003 |
|
RU2231298C1 |
METHOD FOR PREDICTION OF SEVERITY OF HAEMORRHAGIC FEVER WITH RENAL SYNDROME | 2019 |
|
RU2688691C1 |
Authors
Dates
2012-09-20—Published
2011-03-11—Filed